You are here

Home

chemotherapy

Mathematical Modelling in Pharmaceutical Development

Project Leader(s): 

Dr. Jack A. Tuszynski , University of Alberta

Project Website: 

http://mitacs-gw.phys.ualberta.ca/mmpd/

Project team: 
Dr. Thoms Hillen, (University of Alberta)
Dr. Gerda de Vries, (University of Alberta)
Dr. Michael Y. Li, (University of Alberta)
Dr. D. Peter Tieleman, (University of Calgary)
Dr. Lukasz Kurgan, (University of Alberta)
Dr. Eric Cytrynbaum, (University of British Columbia)
Dr. Stephane Portet, (University of Manitoba)
Dr. Siv Sivaloganathan, (University of Waterloo)
Dr. Roderick Melnik, (Wilfrid Laurier University)
Non-academic participants: 

Kinetana, Inc. Biomira, Inc. Project CyberCell Inc. Technology Innovations, LLC National Institute for Nanotechnology Cross Cancer Institute McBride Career Group YeTaDel Foundation Oncovista Inc. Howard J. Greenwald P.C. Multimedia Advanced Computational Infrastructure (MACI) Canadian-European Research Initiative on Nanostructure (CERION)

Funding period: 
July 1, 2021 - March 31, 2021
Tags: 
health

Biomedical Models of Cellular and Physiological Systems and Disease

Project Leader(s): 

Dr. Daniel Coombs, University of British Columbia

Project Website: 

http://www.math.ubc.ca/~coombs/MITACS/index.htm

Project team: 
Dr. Christopher Cairo, University of Alberta
Dr. Eric Cytrynbaum, University of British Columbia
Dr. Leah Keshet, University of British Columbia
Dr. Michael C. Mackey, McGill University
Dr. Bruce Verchere, Child and Family Institute of BC
Dr. Gerda de Vries, University of Alberta
Non-academic participants: 

Juvenile Diabetes Research Foundation

MERCK

National Science Foundation - Washington University, Department of Physics

StemCell Technologies

Funding period: 
February 25, 2022 - March 31, 2021

Diseases such as diabetes, Alzheimer's, HIV and blood disorders present challenges to our society, our healthcare and our basic scientific understanding of physiological processes within the human body. Mathematical modelling can be used to help scientists decipher the processes at work in these complex diseases at a molecular, cellular and organ level. Recently, research team members examined the ways in which drugs such as Filgrastim could be used to replenish levels of white blood cells, a common challenge following chemotherapy.

Tags: 
health